Literature DB >> 21672537

Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage.

Laurie B Joseph1, Donald R Gerecke, Diane E Heck, Adrienne T Black, Patrick J Sinko, Jessica A Cervelli, Robert P Casillas, Michael C Babin, Debra L Laskin, Jeffrey D Laskin.   

Abstract

Sulfur mustard (SM, bis(2-chloroethyl)sulfide) is a bifunctional alkylating agent that causes dermal inflammation, edema and blistering. To investigate the pathogenesis of SM-induced injury, we used a vapor cup model which provides an occlusive environment in which SM is in constant contact with the skin. The dorsal skin of SKH-1 hairless mice was exposed to saturated SM vapor or air control. Histopathological changes, inflammatory markers and DNA damage were analyzed 1-14 days later. After 1 day, SM caused epidermal thinning, stratum corneum shedding, basal cell karyolysis, hemorrhage and macrophage and neutrophil accumulation in the dermis. Cleaved caspase-3 and phosphorylated histone 2A.X (phospho-H2A.X), markers of apoptosis and DNA damage, respectively, were increased whereas proliferating cell nuclear antigen (PCNA) was down-regulated after SM exposure. By 3 days, epithelial cell hypertrophy, edema, parakeratosis and loss of epidermal structures were noted. Enzymes generating pro-inflammatory mediators including myeloperoxidase and cyclooxygenase-2 were upregulated. After 7 days, keratin-10, a differentiation marker, was evident in the stratum corneum. This was associated with an underlying eschar, as neoepidermis began to migrate at the wound edges. Trichrome staining revealed increased collagen deposition in the dermis. PCNA expression in the epidermis was correlated with hyperplasia, hyperkeratosis, and parakeratosis. By 14 days, there was epidermal regeneration with extensive hyperplasia, and reduced expression of cleaved caspase-3, cyclooxygenase-2 and phospho-H2A.X. These findings are consistent with the pathophysiology of SM-induced skin injury in humans suggesting that the hairless mouse can be used to investigate the dermatoxicity of vesicants and the potential efficacy of countermeasures.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21672537      PMCID: PMC3630073          DOI: 10.1016/j.yexmp.2011.05.010

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  79 in total

1.  Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation.

Authors:  J Alfredsson; H Puthalakath; H Martin; A Strasser; G Nilsson
Journal:  Cell Death Differ       Date:  2005-02       Impact factor: 15.828

Review 2.  Vesicants.

Authors:  John McManus; Kermit Huebner
Journal:  Crit Care Clin       Date:  2005-10       Impact factor: 3.598

3.  Time course of lesion development in the hairless guinea-pig model of sulfur mustard-induced dermal injury.

Authors:  Janet M Benson; JeanClare Seagrave; Waylon M Weber; Colleen D Santistevan; Gary R Grotendorst; Gregory S Schultz; Thomas H March
Journal:  Wound Repair Regen       Date:  2011-03-16       Impact factor: 3.617

4.  The role of homologous recombination in the cellular response to sulphur mustard.

Authors:  Paul A Jowsey; Faith M Williams; Peter G Blain
Journal:  Toxicol Lett       Date:  2010-05-07       Impact factor: 4.372

5.  A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis.

Authors:  Felix B Müller; Marcel Huber; Tamar Kinaciyan; Ingrid Hausser; Christina Schaffrath; Thomas Krieg; Daniel Hohl; Bernhard P Korge; Meral J Arin
Journal:  Hum Mol Genet       Date:  2006-02-27       Impact factor: 6.150

6.  2-Chloroethyl ethyl sulfide causes microvesication and inflammation-related histopathological changes in male hairless mouse skin.

Authors:  Anil K Jain; Neera Tewari-Singh; David J Orlicky; Carl W White; Rajesh Agarwal
Journal:  Toxicology       Date:  2011-02-02       Impact factor: 4.221

7.  Mast cells: an unexpected finding in the modulation of cutaneous wound repair by charged beads.

Authors:  Aaron Sasaki; Reid V Mueller; Gong Xi; Richard Sipe; Dave Buck; Jeffrey Hollinger
Journal:  Plast Reconstr Surg       Date:  2003-04-01       Impact factor: 4.730

8.  Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.

Authors:  P H Clingen; J Y-H Wu; J Miller; N Mistry; F Chin; P Wynne; K M Prise; J A Hartley
Journal:  Biochem Pharmacol       Date:  2008-04-16       Impact factor: 5.858

Review 9.  Critical role of mast cells in inflammatory diseases and the effect of acute stress.

Authors:  Theoharis C Theoharides; David E Cochrane
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

10.  Methods of advanced wound management for care of combined traumatic and chemical warfare injuries.

Authors:  John S Graham; Travis W Gerlach; Thomas P Logan; James P Bonar; Richard J Fugo; Robyn B Lee; Matthew A Coatsworth
Journal:  Eplasty       Date:  2008-07-21
View more
  26 in total

1.  Tannic acid mitigates the DMBA/croton oil-induced skin cancer progression in mice.

Authors:  Ferial Majed; Summya Rashid; Abdul Quaiyoom Khan; Sana Nafees; Nemat Ali; Rashid Ali; Rehan Khan; Syed Kazim Hasan; Syed Jafar Mehdi; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2014-11-16       Impact factor: 3.396

2.  2,6-Dithiopurine, a nucleophilic scavenger, protects against mutagenesis in mouse skin treated in vivo with 2-(chloroethyl) ethyl sulfide, a mustard gas analog.

Authors:  Stephen Boulware; Tammy Fields; Elizabeth McIvor; K Leslie Powell; Erika L Abel; Karen M Vasquez; Michael C MacLeod
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-23       Impact factor: 4.219

3.  Myeloperoxidase deficiency attenuates nitrogen mustard-induced skin injuries.

Authors:  Anil K Jain; Neera Tewari-Singh; Swetha Inturi; David J Orlicky; Carl W White; Rajesh Agarwal
Journal:  Toxicology       Date:  2014-03-12       Impact factor: 4.221

4.  Therapeutic potential of a non-steroidal bifunctional anti-inflammatory and anti-cholinergic agent against skin injury induced by sulfur mustard.

Authors:  Yoke-Chen Chang; James D Wang; Rita A Hahn; Marion K Gordon; Laurie B Joseph; Diane E Heck; Ned D Heindel; Sherri C Young; Patrick J Sinko; Robert P Casillas; Jeffrey D Laskin; Debra L Laskin; Donald R Gerecke
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-13       Impact factor: 4.219

Review 5.  Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite.

Authors:  Dinesh Giri Goswami; Rajesh Agarwal; Neera Tewari-Singh
Journal:  Toxicol Lett       Date:  2017-11-12       Impact factor: 4.372

6.  Expression of Laminin γ2 Proteolytic Fragments in Murine Skin Following Exposure to Sulfur Mustard.

Authors:  Yoke-Chen Chang; James D Wang; Hui-Ying Chang; Peihong Zhou; Rita A Hahn; Marion K Gordon; Jeffrey D Laskin; Donald R Gerecke
Journal:  Anat Rec (Hoboken)       Date:  2020-05-18       Impact factor: 2.064

Review 7.  Corneal toxicity induced by vesicating agents and effective treatment options.

Authors:  Dinesh G Goswami; Neera Tewari-Singh; Rajesh Agarwal
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

Review 8.  Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure.

Authors:  Neera Tewari-Singh; Rajesh Agarwal
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

9.  Sulfur mustard induced mast cell degranulation in mouse skin is inhibited by a novel anti-inflammatory and anticholinergic bifunctional prodrug.

Authors:  Laurie B Joseph; Gabriella M Composto; Roberto M Perez; Hong-Duck Kim; Robert P Casillas; Ned D Heindel; Sherri C Young; Carl J Lacey; Jaya Saxena; Christophe D Guillon; Claire R Croutch; Jeffrey D Laskin; Diane E Heck
Journal:  Toxicol Lett       Date:  2017-11-07       Impact factor: 4.372

10.  Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries.

Authors:  Neera Tewari-Singh; Anil K Jain; Swetha Inturi; David A Ammar; Chapla Agarwal; Puneet Tyagi; Uday B Kompella; Robert W Enzenauer; J Mark Petrash; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-24       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.